424B5 1 file001.htm FORM 424(B)(5)

Filed Pursuant to Rule 424(b)(5)
Registration File No.: 333-121067

The information in this preliminary pricing supplement is not complete and may
be changed. This preliminary pricing supplement and the accompanying prospectus
supplements and prospectus are not an offer to sell these securities and we are
not soliciting an offer to buy these securities in any jurisdiction where the
offer or sale is not permitted.

SUBJECT TO COMPLETION, DATED MARCH 22, 2006

PRELIMINARY PRICING SUPPLEMENT No. 16
to Prospectus Supplement dated May 18, 2005
to Prospectus Supplement dated May 18, 2005
and Prospectus dated May 18, 2005

$5,500,000
LEHMAN BROTHERS HOLDINGS INC.
MEDIUM-TERM NOTES, SERIES H
1.50% Notes Due March 29, 2013
Performance Linked to the Common Stock of MEDTRONIC, INC. (MDT)

Because these notes are part of a series of Lehman Brothers Holdings' debt
securities called Medium-Term Notes, Series H, this preliminary pricing
supplement and the accompanying prospectus supplement, dated May 18, 2005 (the
"synthetic convertible prospectus supplement") should also be read with the
accompanying prospectus supplement, dated May 18, 2005 (the "MTN prospectus
supplement") and the accompanying prospectus dated May 18, 2005 (the "base
prospectus"). Terms used here have the meanings given them in the synthetic
convertible prospectus supplement, the MTN prospectus supplement or the base
prospectus, unless the context requires otherwise.

o REFERENCE EQUITY: The common stock of Medtronic, Inc. Medtronic, Inc. is
not involved in this offering and has no obligation with respect to the
notes.

o STATED MATURITY DATE: March 29, 2013, subject to postponement if the
valuation date is postponed.

o INTEREST RATE: 1.50% per annum.

o INTEREST PAYMENT DATES: March 29 and September 29 of each year, beginning
on September 29, 2006.

o INTEREST PAYMENT RECORD DATES: 15 calendar days prior to each interest
payment date.

o PRINCIPAL AMOUNT: $1,000 per note, and in the aggregate, $5,500,000.

o THRESHOLD VALUE: 113.82% of the average execution price per share of common
stock that an affiliate of Lehman Brothers Holdings will pay to hedge
Lehman Brothers Holdings' obligations under the notes.

o EARLIEST REDEMPTION DATE: March 22, 2009.

o REDEMPTION NOTICE PERIOD: 30 calendar days.

o OPTIONAL REPURCHASE NOTICE PERIOD: Eight business days.

o DETERMINATION PERIOD: Three business days.

o MULTIPLIER: The initial multiplier for the shares of common stock of
Medtronic, Inc. is 1.0. The multiplier is subject to adjustment under
various circumstances, as described under the caption "Description of the
Notes--Adjustments to multipliers and to securities included in the
calculation of the settlement value" on page SS-16 of the synthetic
convertible prospectus supplement, including if Medtronic, Inc. pays a
quarterly cash dividend of more than the base dividend of $0.09625 per
share on its shares of common stock. The effective adjustment date for
adjusting the multiplier will be the first business day immediately
following the 19th day of each February, May, August or November and the
valuation date, as applicable.

o STOCK SETTLEMENT: Yes, upon exercise by the holder of the repurchase option
and at the option of Lehman Brothers Holdings at maturity, all as described
under the caption "Description of the Notes--Stock settlement" on page
SS-21 of the synthetic convertible prospectus supplement. Lehman Brothers
Holdings will provide the trustee with prior written notice no later than
the valuation date if it elects the stock settlement option.

o LISTING: The notes will not be listed on any exchange.

Investing in the notes involves risks. Risk Factors begin on page SS-7 of
the synthetic convertible prospectus supplement.

Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or determined if this
preliminary pricing supplement, any accompanying prospectus supplement or any
accompanying prospectus is truthful or complete. Any representation to the
contrary is a criminal offense.

----------------------

Per Note Total
-------- -----
Public offering price............................ 100.00% $5,500,000
Underwriting discount............ ............... 0.25% $13,750
Proceeds to Lehman Brothers Holdings............. 99.75% $5,486,250

----------------------

Lehman Brothers Holdings has granted the underwriter an option to purchase,
within 13 days of the original issuance, up to an additional $825,000 aggregate
principal amount of notes on the same terms and conditions set forth above
solely to cover over-allotments, if any.

The notes are expected to be ready for delivery in book-entry form only through
The Depository Trust Company on or about March 29, 2006.

----------------------
LEHMAN BROTHERS
March , 2006

EXAMPLES OF AMOUNT PAYABLE AT MATURITY OR UPON REDEMPTION OR REPURCHASE

Here are two examples of hypothetical alternative redemption amount
calculations. In each of these examples it is assumed that (a) Medtronic, Inc.
does not change the amount of the quarterly cash dividends that it pays on its
shares of common stock during the term of the notes and (b) that the threshold
value is $60.4611.

EXAMPLE 1. ASSUMING THE SETTLEMENT VALUE IS $45:

Alternative redemption amount per $1,000 note =

$45.00
$1,000 x -------------- = $744.28
$60.4611

As a result, on the maturity date or upon redemption, you would receive $1,000,
plus accrued but unpaid interest, per $1,000 note because $1,000 is greater than
$744.28.

In the case of stock settlement at maturity or upon repurchase in this example,
you would receive, if you held a $1,000 note, 22 shares of common stock of
Medtronic, Inc. plus $10.00 in cash, plus accrued but unpaid interest at
maturity, or 16 shares of common stock of Medtronic, Inc. plus $24.28 in cash,
plus accrued but unpaid interest, upon repurchase. To the extent that you hold
more than $1,000 aggregate principal amount of notes, the calculations of cash
payments in lieu of fractional shares would be made on an aggregate, rather than
on a per $1,000 note, basis. For example, if you held $5,500,000 aggregate
principal amount of notes, you would receive, in total, 122,222 shares of common
stock of Medtronic, Inc. plus $10.00 in cash, plus accrued but unpaid interest,
at maturity, or 90,967 shares of common stock of Medtronic, Inc. plus $25.00 in
cash, plus accrued but unpaid interest, upon repurchase.

EXAMPLE 2. ASSUMING THE SETTLEMENT VALUE IS $75:

Alternative redemption amount per $1,000 note =

$75.00
$1,000 x ---------- = $1,240.46
$60.4611

As a result, on the maturity date or upon redemption, you would receive
$1,240.46, plus accrued but unpaid interest, per $1,000 note because $1,240.46
is greater than $1,000.

In the case of stock settlement at maturity or upon repurchase in this example,
you would receive, if you held a $1,000 note, 16 shares of common stock of
Medtronic, Inc. plus $40.46 in cash, plus accrued but unpaid interest, at
maturity or upon repurchase. To the extent that you hold more than $1,000
aggregate principal amount of notes, the calculations of cash payments in lieu
of fractional shares would be made on an aggregate, rather than on a per $1,000
note, basis. For example, if you held $5,500,000 aggregate principal amount of
notes, you would receive, in total, 90,967 shares of common stock of Medtronic,
Inc. plus $5.00 in cash, plus accrued but unpaid interest, at maturity or upon
repurchase.

To the extent the actual settlement value or threshold value differs from the
values assumed above or that Medtronic, Inc. changes the amount of the quarterly
cash dividends it pays, the results indicated above would be different.

PS-2

THE INDEX STOCK

MEDTRONIC, INC.

Lehman Brothers Holdings has obtained the following information regarding
Medtronic, Inc. from Medtronic, Inc.'s reports filed with the SEC.

Medtronic, Inc. functions in five operating segments, including Cardiac Rhythm
Management; Spinal, Ear, Nose and Throat and Navigation; Neurological and
Diabetes; Vascular; and Cardiac Surgery. Through these five operating segments,
Medtronic, Inc. develops, manufactures, and markets its medical devices in more
than 120 countries worldwide. Medtronic, Inc.'s primary products include those
for heart and vascular disease, neurological disorders, chronic pain, spinal
disorders, diabetes, urologic and digestive system disorders, and eye, ear, nose
and throat disorders.

The index stock is registered under the Securities Exchange Act of 1934.
Companies with securities registered under that Act are required to file
periodically certain financial and other information specified by the SEC.
Information provided to or filed with the SEC can be inspected and copied at the
public reference facilities maintained by the SEC or through the SEC's website
described under "Where You Can Find More Information" on page 58 of the
accompanying base prospectus. In addition, information regarding the index stock
issuer may be obtained from other sources including, but not limited to, press
releases, newspaper articles and other publicly disseminated documents.

HISTORICAL INFORMATION ABOUT THE SHARES OF COMMON STOCK OF MEDTRONIC, INC.

The shares of common stock of Medtronic, Inc. are listed on The New York Stock
Exchange under the symbol "MDT".

The following table presents the high and low closing prices for the shares of
common stock of Medtronic, Inc., as reported on The New York Stock Exchange
during each fiscal quarter in 2003, 2004, 2005 and 2006 (through the business
day immediately prior to the date of this preliminary pricing supplement), and
the closing price at the end of each quarter in 2003, 2004, 2005 and 2006
(through the business day immediately prior to the date of this preliminary
pricing supplement).

The historical prices of the index stock are not necessarily indicative of
future performance. Lehman Brothers Holdings cannot assure you that the prices
of the index stock will not fall below the threshold value or will increase
enough so that the alternative redemption amount will be greater than or equal
to $1,000. The historical prices below have been adjusted to reflect any stock
splits or reverse stock splits.

All information in the table that follows was obtained from Bloomberg L.P.,
without independent verification.

PS-3

HIGH LOW PERIOD END
---- --- ----------
2003
First Quarter .................. $ 47.99 $ 43.10 $ 45.12
Second Quarter ................. 50.30 $ 45.68 $ 47.97
Third Quarter .................. 52.65 $ 46.92 $ 46.92
Fourth Quarter ................. 48.91 $ 43.36 $ 48.61
2004
First Quarter .................. $ 52.00 $ 46.50 $ 47.75
Second Quarter ................. 51.33 $ 46.40 $ 48.72
Third Quarter .................. 51.90 $ 48.55 $ 51.90
Fourth Quarter ................. 53.28 $ 47.01 $ 49.67
2005
First Quarter .................. $ 54.92 $ 48.75 $ 50.95
Second Quarter ................. 53.92 $ 50.30 $ 51.79
Third Quarter .................. 57.85 $ 51.77 $ 53.62
Fourth Quarter ................. 58.49 $ 52.87 $ 57.57
2006
First Quarter (through 03/21/06) $ 59.54 $ 52.66 $ 53.11

PS-4

HYPOTHETICAL RETURNS

The table below illustrates, for a range of hypothetical settlement values
calculated on the valuation date, in each case assuming that the threshold value
is $60.4611:

o the hypothetical alternative redemption amount per $1,000 note;

o the percentage change from the principal amount to the hypothetical
alternative redemption amount;

o the hypothetical total amount payable at stated maturity per $1,000 note
(without interest);

o the hypothetical total rate of return (without interest);

o the hypothetical annualized pre-tax rate of return (without interest);

o the hypothetical total rate of return (including interest); and

o the hypothetical annualized pre-tax rate of return (including interest).

PERCENTAGE HYPOTHETICAL
CHANGE FROM THE TOTAL AMOUNT
PRINCIPAL AMOUNT PAYABLE AT HYPOTHETICAL
HYPOTHETICAL HYPOTHETICAL TO THE STATED HYPOTHETICAL HYPOTHETICAL HYPOTHETICAL ANNUALIZED PRE
SETTLEMENT ALTERNATIVE HYPOTHETICAL MATURITY PER TOTAL RATE OF ANNUALIZED PRE- TOTAL RATE OF TAX RATE OF
LEVEL ON THE REDEMPTION ALTERNATIVE $1,000 NOTE RETURN TAX RATE OF RETURN RETURN
VALUATION AMOUNT PER REDEMPTION (WITHOUT (WITHOUT RETURN (WITHOUT (INCLUDING (INCLUDING
DATE $1,000 NOTE AMOUNT INTEREST) INTEREST) INTEREST) INTEREST) INTEREST)
--------------------------------------------------------------------------------------------------------------------------------

$20.00 $330.79 -66.92% $1,000.00 0.00% 0.00% 10.50% 1.44%
$30.00 $496.19 -50.38% $1,000.00 0.00% 0.00% 10.50% 1.44%
$40.00 $661.58 -33.84% $1,000.00 0.00% 0.00% 10.50% 1.44%
$50.00 $826.98 -17.30% $1,000.00 0.00% 0.00% 10.50% 1.44%
$60.4611 (1) $1,000.00 0.00% $1,000.00 0.00% 0.00% 10.50% 1.44%
$70.00 $1,157.77 15.78% $1,157.77 15.78% 2.11% 26.28% 3.39%
$80.00 $1,323.16 32.32% $1,323.16 32.32% 4.08% 42.82% 5.22%
$90.00 $1,488.56 48.86% $1,488.56 48.86% 5.85% 59.36% 6.88%
$100.00 $1,653.96 65.40% $1,653.96 65.40% 7.45% 75.90% 8.40%

(1) The $60.4611 hypothetical settlement value reflects the assumed threshold
value.

----------------------

For purposes of this table, it is assumed that Medtronic, Inc. does not change
the amount of the quarterly cash dividends that it pays on its shares of common
stock during the term of the notes.

The above figures are for purposes of illustration only. The actual amount
received by investors and the resulting total and pre-tax rates of return will
depend entirely on the actual settlement value determined by the calculation
agent. In particular, the actual settlement value could be lower or higher than
those reflected in the table.

The table above only provides hypothetical return information with regard to
notes held to maturity. It is not applicable in the case of notes repurchased or
redeemed prior to the stated maturity date.

You should compare the features of the notes to other

PS-5

available investments before deciding to purchase the notes. Due to the
uncertainty as to whether the alternative redemption amount, at stated maturity
or in connection with a repurchase or redemption, will be greater than $1,000
per $1,000 note or whether the notes will be redeemed prior to the stated
maturity date, the return on investment with respect to the notes may be higher
or lower than the return available on other securities issued by Lehman Brothers
Holdings or by others and available through Lehman Brothers Inc. You should
reach an investment decision only after carefully considering the suitability of
the notes in light of your particular circumstances.

SUPPLEMENTAL UNITED STATES FEDERAL INCOME TAX CONSEQUENCES

Lehman Brothers Holdings is required to provide the comparable yield to you and,
solely for tax purposes, is also required to provide a projected payment
schedule that includes the actual interest payments on the notes and estimates
the amount and timing of contingent payments on the notes. Lehman Brothers
Holdings has determined that the comparable yield is an annual rate of 5.2845%
compounded semi-annually. Based on the comparable yield, the projected payment
schedule per $1,000 note is $7.50 semi-annually and $1,220.89 due at maturity.
Lehman Brothers Holdings agrees and, by purchasing a note, you agree, for United
States federal income tax purposes, to be bound by Lehman Brothers Holdings'
determination of the comparable yield and projected payment schedule. As a
consequence, for United States federal income tax purposes, you must use the
comparable yield determined by Lehman Brothers Holdings and the projected
payments set forth in the projected payment schedule prepared by Lehman Brothers
Holdings in determining your interest accruals, and the adjustments thereto, in
respect of the notes.

Because there is no statutory, judicial, or administrative authority directly
addressing the characterization of notes with terms such as the notes for United
States federal income tax purposes, it is possible that the Internal Revenue
Service could assert characterizations other than those described in the
accompanying synthetic convertible prospectus supplement that could affect the
timing, amount and character of income, gain, loss or deduction. You should
consult your own tax advisors concerning the federal income tax consequences of
the notes in light of your particular situation. See "United States Federal
Income Tax Consequences" in the accompanying synthetic convertible prospectus
supplement.

PS-6

SUPPLEMENTAL PLAN OF DISTRIBUTION

Lehman Brothers Holdings has agreed to sell to Lehman Brothers Inc. and Lehman
Brothers Inc. has agreed to purchase, all of the notes at the price indicated on
the cover of the pricing supplement.

Lehman Brothers Holdings has agreed to indemnify Lehman Brothers Inc. against
liabilities, including liabilities under the Securities Act of 1933, as amended,
or to contribute to payments that Lehman Brothers Inc. may be required to make
relating to these liabilities as described in the MTN prospectus supplement and
the base prospectus.

Lehman Brothers Inc. will offer the notes initially at a public offering price
equal to the issue price set forth on the cover of the pricing supplement. After
the initial public offering, the public offering price may from time to time be
varied by Lehman Brothers Inc.

Lehman Brothers Holdings has granted to Lehman Brothers Inc. an option to
purchase, at any time within 13 days of the original issuance of the notes, up
to $825,000 additional aggregate principal amount of notes solely to cover
over-allotments. To the extent that the option is exercised, Lehman Brothers
Inc. will be committed, subject to certain conditions, to purchase the
additional notes. If this option is exercised in full, the total public offering
price, the underwriting discount and proceeds to Lehman Brothers Holdings would
be $6,325,000, $15,813 and $6,309,187, respectively.

Lehman Brothers Holdings expects to deliver the notes against payment on or
about March 29, 2006, which is the fifth business day following the date of the
pricing supplement.

Under Rule 15c6-1 of the Exchange Act, trades in the secondary market generally
are required to settle in three business days, unless the parties to any such
trade expressly agree otherwise. Accordingly, if any purchaser wishes to trade
the notes on the date of this preliminary pricing supplement, it will be
required, by virtue of the fact that the notes initially will settle on the
fifth business day following the date of the pricing supplement, to specify an
alternate settlement cycle at the time of any such trade to prevent a failed
settlement.

An affiliate of Lehman Brothers Holdings will enter into a swap transaction in
connection with the notes and will receive customary compensation for that
transaction.

PS-7

$5,500,000

LEHMAN BROTHERS HOLDINGS INC.
MEDIUM-TERM NOTES, SERIES H

1.50% NOTES DUE MARCH 29, 2013
PERFORMANCE LINKED TO THE
COMMON STOCK OF MEDTRONIC, INC. (MDT)

----------------------

PRELIMINARY PRICING SUPPLEMENT
MARCH 22, 2006

(INCLUDING PROSPECTUS SUPPLEMENT
DATED MAY 18, 2005,

PROSPECTUS SUPPLEMENT
DATED MAY 18, 2005 AND

PROSPECTUS
DATED MAY 18, 2005)

----------------------

LEHMAN BROTHERS